Autoactivation of the HeLa 9903 test system during a full moon

Area of Science:

• Cell biology
• Environmental science
• Biochemistry

Background:

• The HeLa 9903 cell line is utilized in the in vitro endocrine disruption assay (OECD 455).
• This assay measures luminescence changes in response to estrogen receptor agonists.
• Autoactivation, or spontaneous luminescence increase, has been observed in this test system.

Purpose of the Study:

• To investigate the underlying cause of autoactivation in the HeLa 9903 cell line.
• To determine if external environmental factors influence the assay's baseline luminescence.

Main Methods:

• HeLa 9903 cells were cultured and seeded under varying moon phases.
• Luminescence was measured the subsequent day.
• Enzyme-linked immunosorbent assay (ELISA) was employed to detect 17β-estradiol expression.

Main Results:

• A statistically significant correlation was found between the phase of the moon and increased cell luminescence.
• Autoactivation was more probable when moonlight visibility exceeded approximately 87.7% (full moon).
• ELISA results indicated that this autoactivation was ligand-independent, not due to endogenous 17β-estradiol production.

Conclusions:

• The phase of the moon is a significant factor influencing the autoactivation of HeLa 9903 cells in vitro.
• This finding represents the first documented relationship between lunar cycles and cell activation in cultured systems.
• Results necessitate careful consideration of lunar phases when planning and conducting studies using this endocrine disruption assay.